Hainan Longevity
Guides & research · The licensed programs

The licensed programs

Boao Lecheng has licensed cell & gene technologies across five approval batches, delivered in its tertiary hospitals with mandatory outcome reporting.

Stem cell — UC-MSC therapy for joints (knee osteoarthritis, meniscus) and type-2 diabetes; MSC courses for cirrhosis and chronic liver dysfunction; adipose-derived programs for metabolism, neurology and dermatology; an amniotic-cell program for ovarian reserve decline.
Immune cell — autologous NK expansion for post-surgery recurrence prevention, immune rebuild after chemotherapy or radiation, and high-risk prevention; dendritic-cell programs for selected solid tumours.
Gene — the zone’s chartered gene-therapy programs, the most advanced tier of the menu.
Infusion & blood — therapeutic plasma exchange (double-filtration apheresis), 1+X functional infusion medicine, mitochondrial & NAD+ protocols, and whole-body immune hyperthermia.

How candidacy works

No program on this list is sold from a menu. The retreat’s assessment comes first; the treating hospital’s specialist panel decides candidacy from your results, and some guests are declined. Program pricing is published by the treating hospitals and confirmed in writing before you commit to anything.

The regulatory frame

These are clinical-stage therapies, lawful inside the pilot zone under its 2013 State Council charter, delivered as disease treatment. Safety & regulation →

Write to us →Tell us where you’re starting from — a care manager replies within one working day.